Proteostasis Therapeutics

Home » Proteostasis Therapeutics

Secondary

Proteostasis Therapeutics

: Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing.

Symbol

PTI

Last Closing Price
$5.47

Shares
7,000,000

Effective Date
December 14, 2017

Underwriters
Leerink Partners, RBC Capital Markets

To view the prospectus for Proteostasis Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253